Monte Carlo Fashions Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 10:46 pm

Competitors of Monte Carlo Fashions Ltd

All Competitor Stocks of Monte Carlo Fashions Ltd

Quarterly Result

Last Updated: August 20, 2025, 6:50 am

Below is a detailed analysis of the quarterly data for Monte Carlo Fashions Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 139.00 Cr.. The value appears to be declining and may need further review. It has decreased from 206.00 Cr. (Mar 2025) to 139.00 Cr., marking a decrease of 67.00 Cr..
• For Expenses, as of Jun 2025, the value is 144.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 200.00 Cr. (Mar 2025) to 144.00 Cr., marking a decrease of 56.00 Cr..
• For Operating Profit, as of Jun 2025, the value is -6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to -6.00 Cr., marking a decrease of 12.00 Cr..
• For OPM %, as of Jun 2025, the value is -4.00%. The value appears to be declining and may need further review. It has decreased from 3.00% (Mar 2025) to -4.00%, marking a decrease of 7.00%.
• For Other Income, as of Jun 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 11.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 15.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -22.00 Cr.. The value appears to be declining and may need further review. It has decreased from -9.00 Cr. (Mar 2025) to -22.00 Cr., marking a decrease of 13.00 Cr..
• For Tax %, as of Jun 2025, the value is -25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 9.00% (Mar 2025) to -25.00%, marking a decrease of 34.00%.
• For Net Profit, as of Jun 2025, the value is -16.00 Cr.. The value appears to be declining and may need further review. It has decreased from -10.00 Cr. (Mar 2025) to -16.00 Cr., marking a decrease of 6.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -7.87. The value appears to be declining and may need further review. It has decreased from -4.96 (Mar 2025) to -7.87, marking a decrease of 2.91.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:44 pm

Balance Sheet

Last Updated: June 16, 2025, 11:41 am

Below is a detailed analysis of the balance sheet data for Monte Carlo Fashions Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 21.00 Cr..
• For Reserves, as of Mar 2025, the value is 813.00 Cr.. The value appears strong and on an upward trend. It has increased from 775.00 Cr. (Mar 2024) to 813.00 Cr., marking an increase of 38.00 Cr..
• For Borrowings, as of Mar 2025, the value is 521.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 382.00 Cr. (Mar 2024) to 521.00 Cr., marking an increase of 139.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 367.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 339.00 Cr. (Mar 2024) to 367.00 Cr., marking an increase of 28.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,722.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,517.00 Cr. (Mar 2024) to 1,722.00 Cr., marking an increase of 205.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 390.00 Cr.. The value appears strong and on an upward trend. It has increased from 328.00 Cr. (Mar 2024) to 390.00 Cr., marking an increase of 62.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 260.00 Cr.. The value appears strong and on an upward trend. It has increased from 241.00 Cr. (Mar 2024) to 260.00 Cr., marking an increase of 19.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,072.00 Cr.. The value appears strong and on an upward trend. It has increased from 949.00 Cr. (Mar 2024) to 1,072.00 Cr., marking an increase of 123.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,722.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,517.00 Cr. (Mar 2024) to 1,722.00 Cr., marking an increase of 205.00 Cr..

Notably, the Reserves (813.00 Cr.) exceed the Borrowings (521.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Monte Carlo Fashions Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 28.91. This value is within the healthy range. It has decreased from 63.92 (Mar 23) to 28.91, marking a decrease of 35.01.
• For Diluted EPS (Rs.), as of Mar 24, the value is 28.91. This value is within the healthy range. It has decreased from 63.92 (Mar 23) to 28.91, marking a decrease of 35.01.
• For Cash EPS (Rs.), as of Mar 24, the value is 53.62. This value is within the healthy range. It has decreased from 84.08 (Mar 23) to 53.62, marking a decrease of 30.46.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 383.40. It has increased from 374.53 (Mar 23) to 383.40, marking an increase of 8.87.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 383.40. It has increased from 374.53 (Mar 23) to 383.40, marking an increase of 8.87.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 512.26. It has decreased from 539.17 (Mar 23) to 512.26, marking a decrease of 26.91.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 81.70. This value is within the healthy range. It has decreased from 115.02 (Mar 23) to 81.70, marking a decrease of 33.32.
• For PBIT / Share (Rs.), as of Mar 24, the value is 56.99. This value is within the healthy range. It has decreased from 94.87 (Mar 23) to 56.99, marking a decrease of 37.88.
• For PBT / Share (Rs.), as of Mar 24, the value is 38.91. This value is within the healthy range. It has decreased from 83.07 (Mar 23) to 38.91, marking a decrease of 44.16.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 28.91. This value is within the healthy range. It has decreased from 63.93 (Mar 23) to 28.91, marking a decrease of 35.02.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 28.91. This value is within the healthy range. It has decreased from 63.93 (Mar 23) to 28.91, marking a decrease of 35.02.
• For PBDIT Margin (%), as of Mar 24, the value is 15.94. This value is within the healthy range. It has decreased from 21.33 (Mar 23) to 15.94, marking a decrease of 5.39.
• For PBIT Margin (%), as of Mar 24, the value is 11.12. This value is within the healthy range. It has decreased from 17.59 (Mar 23) to 11.12, marking a decrease of 6.47.
• For PBT Margin (%), as of Mar 24, the value is 7.59. This value is below the healthy minimum of 10. It has decreased from 15.40 (Mar 23) to 7.59, marking a decrease of 7.81.
• For Net Profit Margin (%), as of Mar 24, the value is 5.64. This value is within the healthy range. It has decreased from 11.85 (Mar 23) to 5.64, marking a decrease of 6.21.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 5.64. This value is below the healthy minimum of 8. It has decreased from 11.85 (Mar 23) to 5.64, marking a decrease of 6.21.
• For Return on Networth / Equity (%), as of Mar 24, the value is 7.54. This value is below the healthy minimum of 15. It has decreased from 17.06 (Mar 23) to 7.54, marking a decrease of 9.52.
• For Return on Capital Employeed (%), as of Mar 24, the value is 11.91. This value is within the healthy range. It has decreased from 20.64 (Mar 23) to 11.91, marking a decrease of 8.73.
• For Return On Assets (%), as of Mar 24, the value is 3.95. This value is below the healthy minimum of 5. It has decreased from 8.85 (Mar 23) to 3.95, marking a decrease of 4.90.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.16. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 23) to 0.16, marking an increase of 0.16.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.43. This value is within the healthy range. It has increased from 0.26 (Mar 23) to 0.43, marking an increase of 0.17.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.70. It has decreased from 0.85 (Mar 23) to 0.70, marking a decrease of 0.15.
• For Current Ratio (X), as of Mar 24, the value is 1.88. This value is within the healthy range. It has decreased from 1.95 (Mar 23) to 1.88, marking a decrease of 0.07.
• For Quick Ratio (X), as of Mar 24, the value is 1.05. This value is within the healthy range. It has decreased from 1.11 (Mar 23) to 1.05, marking a decrease of 0.06.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.26. This value is below the healthy minimum of 4. It has decreased from 0.37 (Mar 23) to 0.26, marking a decrease of 0.11.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 69.18. This value exceeds the healthy maximum of 50. It has increased from 31.27 (Mar 23) to 69.18, marking an increase of 37.91.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 37.30. This value is within the healthy range. It has increased from 23.78 (Mar 23) to 37.30, marking an increase of 13.52.
• For Earning Retention Ratio (%), as of Mar 24, the value is 30.82. This value is below the healthy minimum of 40. It has decreased from 68.73 (Mar 23) to 30.82, marking a decrease of 37.91.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 62.70. This value is within the healthy range. It has decreased from 76.22 (Mar 23) to 62.70, marking a decrease of 13.52.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 4.52. This value is within the healthy range. It has decreased from 9.75 (Mar 23) to 4.52, marking a decrease of 5.23.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.60. This value is below the healthy minimum of 3. It has decreased from 6.42 (Mar 23) to 2.60, marking a decrease of 3.82.
• For Enterprise Value (Cr.), as of Mar 24, the value is 1,624.64. It has increased from 1,478.99 (Mar 23) to 1,624.64, marking an increase of 145.65.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.53. This value is within the healthy range. It has increased from 1.32 (Mar 23) to 1.53, marking an increase of 0.21.
• For EV / EBITDA (X), as of Mar 24, the value is 9.59. This value is within the healthy range. It has increased from 6.20 (Mar 23) to 9.59, marking an increase of 3.39.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.21. This value is within the healthy range. It has increased from 1.16 (Mar 23) to 1.21, marking an increase of 0.05.
• For Retention Ratios (%), as of Mar 24, the value is 30.81. This value is within the healthy range. It has decreased from 68.72 (Mar 23) to 30.81, marking a decrease of 37.91.
• For Price / BV (X), as of Mar 24, the value is 1.62. This value is within the healthy range. It has decreased from 1.66 (Mar 23) to 1.62, marking a decrease of 0.04.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.21. This value is within the healthy range. It has increased from 1.16 (Mar 23) to 1.21, marking an increase of 0.05.
• For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.10 (Mar 23) to 0.04, marking a decrease of 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness